Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Eris Lifesciences Ltd ( (IN:ERIS) ) has shared an update.
Eris Lifesciences Ltd’s board has approved the acquisition of a 30% stake in its subsidiary, Swiss Parenterals Limited, by issuing over 2.3 million equity shares on a preferential basis. This strategic move aims to strengthen Eris Lifesciences’ control over its subsidiary, potentially enhancing its market position and operational capabilities.
More about Eris Lifesciences Ltd
Eris Lifesciences Ltd is a company operating in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company is known for its emphasis on branded formulations and has a significant presence in the Indian market.
Average Trading Volume: 4,221
Technical Sentiment Signal: Buy
Current Market Cap: 226.7B INR
See more data about ERIS stock on TipRanks’ Stock Analysis page.